Empresa VBI Vaccines Inc. Toronto S.E.
Acciones
VBV
CA91822J1030
Biotecnología e investigación médica
Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4,82 CAD | -5,12 % | -7,66 % | -10,58 % |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
License
41,4
%
| - | - | 4 | 41,4 % | - |
Vaccines
35,8
%
| 1 | 86,0 % | 3 | 35,8 % | +233,73 % |
Research & Development Service
22,8
%
| 0 | 14,0 % | 2 | 22,8 % | +1.210,60 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China/Hong Kong
64,3
%
| 0 | 6,1 % | 6 | 64,3 % | +8.362,12 % |
United States
21,3
%
| 1 | 64,2 % | 2 | 21,3 % | +165,47 % |
Europe
12,5
%
| 0 | 0,6 % | 1 | 12,5 % | +17.983,33 % |
Israel
1,9
%
| 0 | 29,1 % | 0 | 1,9 % | -46,98 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01/05/16 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 09/07/15 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 06/05/16 |
Chief Tech/Sci/R&D Officer | 69 | 01/02/16 | |
Nicole Anderson
IRC | Investor Relations Contact | - | 01/10/17 |
Corporate Officer/Principal | 59 | 23/05/17 | |
Misha Nossov
PRN | Corporate Officer/Principal | - | 01/05/10 |
John Dillman
PRN | Corporate Officer/Principal | 56 | 12/07/22 |
Avi Mazaltov
PRN | Corporate Officer/Principal | 62 | 30/03/17 |
T. Buckley
PRN | Corporate Officer/Principal | 48 | 01/01/01 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 24/04/23 |
Steven Gillis
CHM | Chairman | 71 | 01/01/05 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01/05/16 |
Damian Braga
BRD | Director/Board Member | 68 | 09/03/20 |
Michel de Wilde
BRD | Director/Board Member | 74 | 01/05/16 |
Blaine McKee
BRD | Director/Board Member | 59 | 11/01/19 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 09/07/15 |
Joanne Cordeiro
BRD | Director/Board Member | 66 | 15/04/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 28 682 275 | 25 243 110 ( 88,01 %) | 0 | 88,01 % |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,37 % | 44,96 mil M | |
-1,01 % | 42,65 mil M | |
+46,00 % | 41,85 mil M | |
-5,31 % | 29,04 mil M | |
+9,34 % | 26,08 mil M | |
-21,69 % | 19,03 mil M | |
+6,23 % | 12,75 mil M | |
+26,99 % | 12,06 mil M | |
-3,38 % | 11,75 mil M |
- Bolsa de valores
- Acciones
- Acción VBIV
- Acción VBV
- Empresa VBI Vaccines Inc.